To investigate whether SMAD4 enhanced human NK cell-mediated cytotoxicity against CRC cells, the cytotoxicity assay were performed to assess the effects of SMAD4 overexpression on NK cell-mediated cytotoxicity towards various CRC cell lines, including HCT-116, SW480, and SW620. The gene discussed is SMAD4; the disease is colorectal carcinoma.